These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 22573845)

  • 1. Maternal HIV-1 disease progression 18-24 months postdelivery according to antiretroviral prophylaxis regimen (triple-antiretroviral prophylaxis during pregnancy and breastfeeding vs zidovudine/single-dose nevirapine prophylaxis): The Kesho Bora randomized controlled trial.
    Kesho Bora Study Group
    Clin Infect Dis; 2012 Aug; 55(3):449-60. PubMed ID: 22573845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral interventions for preventing breast milk transmission of HIV.
    White AB; Mirjahangir JF; Horvath H; Anglemyer A; Read JS
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD011323. PubMed ID: 25280769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and effectiveness of antiretroviral drugs during pregnancy, delivery and breastfeeding for prevention of mother-to-child transmission of HIV-1: the Kesho Bora Multicentre Collaborative Study rationale, design, and implementation challenges.
    Kesho Bora Study Group
    Contemp Clin Trials; 2011 Jan; 32(1):74-85. PubMed ID: 20854932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early infant feeding patterns and HIV-free survival: findings from the Kesho-Bora trial (Burkina Faso, Kenya, South Africa).
    Cournil A; Van de Perre P; Cames C; de Vincenzi I; Read JS; Luchters S; Meda N; Naidu K; Newell ML; Bork K;
    Pediatr Infect Dis J; 2015 Feb; 34(2):168-74. PubMed ID: 25741969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
    Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
    J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal anaemia and duration of zidovudine in antiretroviral regimens for preventing mother-to-child transmission: a randomized trial in three African countries.
    Sartorius BK; Chersich MF; Mwaura M; Meda N; Temmerman M; Newell ML; Farley TM; Luchters S;
    BMC Infect Dis; 2013 Nov; 13():522. PubMed ID: 24192332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial.
    Jamieson DJ; Chasela CS; Hudgens MG; King CC; Kourtis AP; Kayira D; Hosseinipour MC; Kamwendo DD; Ellington SR; Wiener JB; Fiscus SA; Tegha G; Mofolo IA; Sichali DS; Adair LS; Knight RJ; Martinson F; Kacheche Z; Soko A; Hoffman I; van der Horst C;
    Lancet; 2012 Jun; 379(9835):2449-2458. PubMed ID: 22541418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.
    Thior I; Lockman S; Smeaton LM; Shapiro RL; Wester C; Heymann SJ; Gilbert PB; Stevens L; Peter T; Kim S; van Widenfelt E; Moffat C; Ndase P; Arimi P; Kebaabetswe P; Mazonde P; Makhema J; McIntosh K; Novitsky V; Lee TH; Marlink R; Lagakos S; Essex M;
    JAMA; 2006 Aug; 296(7):794-805. PubMed ID: 16905785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4, viral load response, and adherence among antiretroviral-naive breast-feeding women receiving triple antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV in Kisumu, Kenya.
    Okonji JA; Zeh C; Weidle PJ; Williamson J; Akoth B; Masaba RO; Fowler MG; Thomas TK
    J Acquir Immune Defic Syndr; 2012 Oct; 61(2):249-57. PubMed ID: 22692094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV transmission and 24-month survival in a randomized trial of HAART to prevent MTCT during pregnancy and breastfeeding in Botswana.
    Shapiro RL; Kitch D; Ogwu A; Hughes MD; Lockman S; Powis K; Souda S; Moffat C; Moyo S; McIntosh K; van Widenfelt E; Zwerski S; Mazhani L; Makhema J; Essex M
    AIDS; 2013 Jul; 27(12):1911-20. PubMed ID: 24180000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of maternal highly active antiretroviral therapy and short-course combination antiretrovirals for prevention of mother-to-child transmission on early infant infection rates at the Mulago national referral hospital in Kampala, Uganda, January 2007 to May 2009.
    Namukwaya Z; Mudiope P; Kekitiinwa A; Musoke P; Matovu J; Kayma S; Salmond W; Bitarakwate E; Mubiru M; Maganda A; Galla M; Byamugisha J; Fowler MG
    J Acquir Immune Defic Syndr; 2011 Jan; 56(1):69-75. PubMed ID: 21099692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eighteen-month follow-up of HIV-1-infected mothers and their children enrolled in the Kesho Bora study observational cohorts.
    Kesho Bora Study Group
    J Acquir Immune Defic Syndr; 2010 Aug; 54(5):533-41. PubMed ID: 20543706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothers.
    Ciaranello AL; Perez F; Maruva M; Chu J; Engelsmann B; Keatinge J; Walensky RP; Mushavi A; Mugwagwa R; Dabis F; Freedberg KA;
    PLoS One; 2011; 6(6):e20224. PubMed ID: 21655097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes in a cohort of women who discontinued maternal triple-antiretroviral regimens initially used to prevent mother-to-child transmission during pregnancy and breastfeeding--Kenya, 2003-2009.
    Minniear TD; Girde S; Angira F; Mills LA; Zeh C; Peters PJ; Masaba R; Lando R; Thomas TK; Taylor AW;
    PLoS One; 2014; 9(4):e93556. PubMed ID: 24733021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postpartum weight change among HIV-infected mothers by antiretroviral prophylaxis and infant feeding modality in a research setting.
    Cames C; Cournil A; de Vincenzi I; Gaillard P; Meda N; Luchters S; Nduati R; Naidu K; Newell ML; Read JS; Bork K;
    AIDS; 2014 Jan; 28(1):85-94. PubMed ID: 24413262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions for preventing late postnatal mother-to-child transmission of HIV.
    Horvath T; Madi BC; Iuppa IM; Kennedy GE; Rutherford G; Read JS
    Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD006734. PubMed ID: 19160297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.